MDA Staff

Blog Post

Clinical Trial Alert: LGMD2I Participants Sought for a Phase 3 Study

Blog Post

Clinical Trial Alert: Mitsubishi Tanabe Pharma Seeks Participants for a Phase 3 ALS Study

Clinical Trial Alert: LGMD2E Participants Sought for a Phase 1/2a Gene Delivery Study

Blog Post

Clinical Trial Alert: Individuals with SMA Type 3 Sought for a Phase 2 Study

Featured Article

2019 Lasting Impression Photo Contest Winners

MDA logo
Blog Post

Mallinckrodt Pharmaceuticals Releases Statement to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD

MDA logo
Blog Post

Solid Biosciences Releases Letter to DMD Community Announcing Update on IGNITE DMD Trial, Resolution of Serious Adverse Event

MDA logo
Blog Post

Wave Life Sciences Releases Letter to DMD Community Announcing Discontinuation of Clinical Trials Program for Therapies Amenable to Skipping Exons 51 and 53

Blog Post

New MDA Educational Programs for Clinicians Offer a Detailed View on Selected Topics in Neuromuscular Disease

MDA logo
Blog Post

Santhera Pharmaceuticals Releases Letter to DMD Community Announcing Temporary Suspension of Enrollment in BreatheDMD Expanded Access Program